[Retracted] Oral Administration of Gintonin Protects the Brains of Mice against Aβ-Induced Alzheimer Disease Pathology: Antioxidant and Anti-Inflammatory Effects

Figure 4

Effects of gintonin against Aβ-induced synaptic impairment in the brains of mice: (a) western blot images and the respective graphs for the expression of PSD-95, syntaxin, SNAP-25, and SNAP-23 in the saline, Aβ, Aβ+gintonin, and gintonin-alone treatment groups; (b, c) immunofluorescence analysis of SNAP-23 and PSD-95 in the cortex and hippocampus of the experimental mice. A significant difference between Aβ- and saline-treated mice; ^#a significant difference from the Aβ+Gt-treated group. The data are shown as the mean (SD) of three experiments. ^#; ; , . Gt: gintonin; Aβ: amyloid-beta; DAPI: 4,6-diamidino-2-phenylindole; n: not significant.

(a)

(b)

(c)